{"id":450491,"date":"2021-03-04T07:33:08","date_gmt":"2021-03-04T12:33:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450491"},"modified":"2021-03-04T07:33:08","modified_gmt":"2021-03-04T12:33:08","slug":"solid-biosciences-announces-appointments-to-management-team-and-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/","title":{"rendered":"Solid Biosciences Announces Appointments to Management Team and Board of Directors"},"content":{"rendered":"
\n

-Adding senior level experience to help advance programs for Duchenne muscular dystrophy-<\/p>\n

CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced today that Erin Powers Brennan has joined the company as Chief Legal Officer and Joel Schneider, Ph.D., has been promoted to Chief Operating Officer. The Company also announced the appointment of Clare Kahn, Ph.D., and Georgia Keresty, Ph.D., M.P.H., to its Board of Directors.<\/p>\n

\u201cErin and Joel are two highly respected industry leaders who, in addition to their business acumen, share our passion for making a difference in the lives of patients with Duchenne and their families,\u201d said Ilan Ganot, Co-Founder, President and Chief Executive Officer of Solid Biosciences. \u201cJoel was Solid\u2019s first employee and has been an instrumental thought partner in all our corporate milestones and building our unique disease-focused business model. I\u2019m also excited to welcome Erin, who brings more than 20 years of experience developing legal strategies across a broad range of complex, novel matters in the highly regulated healthcare and life sciences industry.\u201d<\/p>\n

\u201cThe addition of Clare and Georgia strengthens our Board by bringing new insights from their respective careers that can help guide the Company in realizing its mission,\u201d said Ian F. Smith, Chairman of the Board of Solid Biosciences. \u201cOn behalf of the entire board, I welcome them and look forward to working with them in continued support of the Company as it works to realize the differentiated potential of SGT-001 and additional opportunities to improve outcomes for patients with Duchenne.\u201d<\/p>\n

Ms. Brennan was most recently SVP, General Counsel & Secretary at Covetrus Inc., where she was the lead legal executive for the animal health technology, pharmacy, and services business with over $4 billion annual revenue and 5,500 employees in 19 countries. In her role at Solid Biosciences, Ms. Brennan will be responsible for all aspects of the Company\u2019s legal and compliance affairs. Ms. Brennan joined Solid Biosciences on March 1, 2021.<\/p>\n

In his previous roles at Solid, Dr. Schneider was responsible for sourcing and validating novel scientific approaches, including the proprietary and differentiated microdystrophin construct that is the foundation of the Company\u2019s lead gene therapy candidate, SGT-001. Most recently, Dr. Schneider was responsible for overseeing the GMP implementation strategy of our next-generation manufacturing process; his responsibilities will now grow to include corporate and technical operations, quality, patient advocacy, communications, corporate strategy, and human resources. The promotion was effective March 2, 2021.<\/p>\n

Carl Morris, Ph.D., Chief Scientific Officer, will also broaden his responsibilities to include all laboratory-based departments by overseeing process and analytical development, in addition to the Company\u2019s research and development efforts.<\/p>\n

Dr. Kahn brings more than 30 years of experience in the pharmaceutical industry with a proven leadership record in strategic pharmaceutical development, registration, and product lifecycle management. Since retiring as head of Worldwide Regulatory Strategy for the Global Innovative Pharma Portfolio at Pfizer, she has advised multiple start-up and established companies. She serves as R&D Strategy Officer for X-VAX Technology Inc. and is a member of the Advisory Board of KBP Biosciences.<\/p>\n

Dr. Keresty has an accomplished career of more than 30 years in the healthcare industry, having recently completed 3 years as R&D Chief Operating Officer of Takeda Pharmaceuticals and the prior 16 years as an executive at Johnson & Johnson.\u00a0 She serves on the boards of Aspen Technologies Inc. and Commissioning Agents Inc.<\/p>\n

Dr. Kahn and Dr. Keresty began their tenure on the Solid Biosciences Board of Directors at the March 2, 2021 meeting.<\/p>\n

\n About Solid Biosciences
<\/strong>Solid Biosciences is a life sciences company focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Disease-focused and founded by a family directly impacted by Duchenne, our mandate is simple yet comprehensive \u2013 work to address the disease at its core by correcting the underlying mutation that causes Duchenne with our lead gene therapy candidate, SGT-001. For more information, please visit\u00a0www.solidbio.com<\/u><\/a>.<\/p>\n

\n Investor Contact:<\/strong>
\n
David Carey
FINN Partners
212-867-1768
David.Carey@finnpartners.com<\/a><\/p>\n

\n Media Contact:<\/strong>
\n
Erich Sandoval
FINN Partners
917-497-2867
Erich.Sandoval@finnpartners.com<\/a><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

-Adding senior level experience to help advance programs for Duchenne muscular dystrophy- CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced today that Erin Powers Brennan has joined the company as Chief Legal Officer and Joel Schneider, Ph.D., has been promoted to Chief Operating Officer. The Company also announced the appointment of Clare Kahn, Ph.D., and Georgia Keresty, Ph.D., M.P.H., to its Board of Directors. \u201cErin and Joel are two highly respected industry leaders who, in addition to their business acumen, share our passion for making a difference in the lives of patients with Duchenne and their families,\u201d said Ilan Ganot, … <\/p>\n

Continue reading “Solid Biosciences Announces Appointments to Management Team and Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450491","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSolid Biosciences Announces Appointments to Management Team and Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences Announces Appointments to Management Team and Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"-Adding senior level experience to help advance programs for Duchenne muscular dystrophy- CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced today that Erin Powers Brennan has joined the company as Chief Legal Officer and Joel Schneider, Ph.D., has been promoted to Chief Operating Officer. The Company also announced the appointment of Clare Kahn, Ph.D., and Georgia Keresty, Ph.D., M.P.H., to its Board of Directors. \u201cErin and Joel are two highly respected industry leaders who, in addition to their business acumen, share our passion for making a difference in the lives of patients with Duchenne and their families,\u201d said Ilan Ganot, … Continue reading "Solid Biosciences Announces Appointments to Management Team and Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T12:33:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences Announces Appointments to Management Team and Board of Directors\",\"datePublished\":\"2021-03-04T12:33:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/\"},\"wordCount\":698,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/\",\"name\":\"Solid Biosciences Announces Appointments to Management Team and Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=\",\"datePublished\":\"2021-03-04T12:33:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences Announces Appointments to Management Team and Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences Announces Appointments to Management Team and Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences Announces Appointments to Management Team and Board of Directors - Market Newsdesk","og_description":"-Adding senior level experience to help advance programs for Duchenne muscular dystrophy- CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced today that Erin Powers Brennan has joined the company as Chief Legal Officer and Joel Schneider, Ph.D., has been promoted to Chief Operating Officer. The Company also announced the appointment of Clare Kahn, Ph.D., and Georgia Keresty, Ph.D., M.P.H., to its Board of Directors. \u201cErin and Joel are two highly respected industry leaders who, in addition to their business acumen, share our passion for making a difference in the lives of patients with Duchenne and their families,\u201d said Ilan Ganot, … Continue reading \"Solid Biosciences Announces Appointments to Management Team and Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T12:33:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences Announces Appointments to Management Team and Board of Directors","datePublished":"2021-03-04T12:33:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/"},"wordCount":698,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/","name":"Solid Biosciences Announces Appointments to Management Team and Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=","datePublished":"2021-03-04T12:33:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4NiM0MDQ3OTA0IzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointments-to-management-team-and-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences Announces Appointments to Management Team and Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450491"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450491\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}